Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasm Metastasis × Ropivacaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 16 Breast Neoplasms 15 Pain 8 Agnosia 6 Prostatic Neoplasms 5 Lung Neoplasms 5 Neoplasms 4 Stomach Neoplasms 3 Colonic Neoplasms 3 Supratentorial Neoplasms 2 Postoperative Complications 2 Colorectal Neoplasms 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Sleep Deprivation 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pain, Intractable 1 Ovarian Cysts 1 Oropharyngeal Neoplasms 1 Neuroblastoma 1 Neoplasm Metastasis 1 Meningioma 1 Malignant Neoplasms of Male Genital Organs 1 Liver Neoplasms 1 Liver Diseases 1 Kidney Neoplasms 1 Intraoperative Complications 1 Head and Neck Neoplasms 1

Interventions

pembrolizumab 134 Gemcitabine 122 Capecitabine 113 Fluorouracil 106 Paclitaxel 105 Oxaliplatin 96 Bevacizumab 95 Nivolumab 90 Leucovorin 89 Docetaxel 80 Radiosurgery 78 Irinotecan 78 Cisplatin 75 Carboplatin 74 Magnetic Resonance Spectroscopy 65 Cyclophosphamide 62 Cetuximab 60 Biopsy 54 Specimen Handling 52 Trastuzumab 50 Radiotherapy 48 Ipilimumab 44 Everolimus 41 Drug Therapy 40 Pemetrexed 39 Albumin-Bound Paclitaxel 39 130-nm albumin-bound paclitaxel 38 Doxorubicin 36 aldesleukin 35 Fulvestrant 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01194843 2015-04-21

DPO

Centre Leon Berard

Phase NA Completed

Neoplasm Metastasis, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡